Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak

MONTREAL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX) announced today that it has filed and is in the process of maili...

How might the interim order and the proxy materials impact TH's stock liquidity and price volatility leading up to the September 12 special meeting? What is the timeline for required regulatory and shareholder approvals, and when is the transaction expected to close? What are the specific terms and valuation of the acquisition, including the share exchange ratio, and how will they affect current TH shareholders?
Symbol: THTX
Mergers
23 days ago
Read more globenewswire

Aramark Completes Debt Repricing

PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE:ARMK), a global leader in food and facilities management, announced the successful completion of a favorable repricing for the Company’s 2028 Term Loan ...

How does the new SOFR + 175 bps term loan compare to the financing terms of peer companies in the food and facilities management sector? What impact could this debt repricing have on ARMK's credit rating and the pricing of its future debt issuances? How will the reduced interest expense from the loan repricing affect Aramark's earnings per share and cash flow outlook?
Symbol: ARMK
Debt
23 days ago
Read more businesswire

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

Provides SGX945 Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage bioph...

What is the potential market size and competitive landscape for a Behçet's disease therapy, and how could that impact long-term revenue forecasts? What is the expected timeline for FDA approval and market launch of SGX945, and how might that influence investor sentiment? How will the orphan drug designation affect Soligenix's valuation and short-term stock movement?
Symbol: SNGX
Regulatory
23 days ago
Read more prnewswire

Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases

REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures

How does the 75% clinical benefit rate compare to existing therapies and pipeline competitors, and what impact could this have on market share and partnership opportunities? What are the regulatory pathways and expected timeline for FDA approval of REYOBIQ in leptomeningeal metastases, and how might that influence near‑term price volatility? How will the positive REYOBIQ trial results affect Plus Therapeutics' revenue forecasts and valuation multiples?
Symbol: PLUS
Clinical trials
23 days ago
Read more globenewswire

Promising Outcome From Collaboration With Dundee Sustainable Technologies

TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce promising results from a program of metallurgical t...

How might this partnership and its outcomes influence Revival Gold's valuation relative to other junior gold producers in the sector? What are the expected timelines and costs for scaling up the DST collaboration to commercial operations at the Beartrack-Arnett project? How will the promising results from the Glasslock Process™ affect Revival Gold's projected gold production and resource estimates?
Symbol: RVG
Collaboration
23 days ago
Read more globenewswire